M3 (MTHRY) Marketable Securities: $195 Mil (As of Mar. 2026)


MTHRY M3 Inc MTHRY
82 GF Score
Price $5.83
GF Value $7.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is M3 Marketable Securities?

M3 MTHRY +3.19% 82 Marketable Securities is $195 Mil as of Mar. 2026. GuruFocus rates MTHRY with a GF Score™ of 82/100 and a GF Value™ of $7.89 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. M3's Marketable Securities for the quarter that ended in Mar. 2026 was $195 Mil.

M3's annual Marketable Securities increased from Mar. 2024 ($201 Mil) to Mar. 2025 ($213 Mil) but then declined from Mar. 2025 ($213 Mil) to Mar. 2026 ($195 Mil).

M3  (OTCPK:MTHRY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

M3 Marketable Securities Related Terms

M3 Marketable Securities Historical Data

* Premium members only.

The historical data trend for M3's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 Marketable Securities Chart

M3 Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 311.72 210.00 201.36 213.48 194.65

M3 Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.48 259.22 234.86 256.19 194.65
MTHRY
82GF Score
M3 Inc MTHRY
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M3 Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $195 Mil mean?
M3 (MTHRY) has a Marketable Securities of $195 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on M3 and its competitors.
Is M3's Marketable Securities too high?
M3's current Marketable Securities is $195 Mil. Overall, M3 has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's Marketable Securities compare to VEEV and BTSG?
M3's Marketable Securities of $195 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on M3 and its competitors. M3's current Marketable Securities is $195 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.89, compared to a current price of $5.83 — trading 26.1% below its estimated fair value. The current Marketable Securities is $195 Mil. M3's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For M3 (MTHRY), the current Marketable Securities is $195 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (MTHRY) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of $5.83 is trading 26.1% below its estimated GF Value™ of $7.89. GuruFocus considers M3 to be Modestly Undervalued.

Key valuation signals for MTHRY:

  • Marketable Securities: $195 Mil
  • GF Value™: $7.89 vs. price of $5.83 (26.1% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M3 Business Description

Other Exchanges 2413:Japan4YC:Germany
Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score

Get the complete analysis for MTHRY

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.83
Price
$7.89
GF Value